Discrimination of acute graft-versus-host disease from infections by enumeration of peripheral blood interferon-γ spot-forming cells

Infections may coexist and in certain circumstances aggravate acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. Early detection of aGVHD is often difficult in patients with concurrent infections. Using an enzyme-linked immunospot assay that reflects on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 2006-02, Vol.81 (4), p.632-635
Hauptverfasser: WILL, Andrew, WYNN, Robert, TAMAKI, Shigehisa, KAWAKAMI, Keiki, KAGEYAMA, Shinichi, NAKANO, Takashi, YAMAMOTO, Hatsumi, KOMADA, Yoshihiro, HIRAYAMA, Masahiro, AZUMA, Eiichi, KUMAMOTO, Tadashi, IWAMOTO, Shotaro, NASHIDA, Yuji, ARAKI, Mariko, YAMADA, Hiroshi, DIDA, Francis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Infections may coexist and in certain circumstances aggravate acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. Early detection of aGVHD is often difficult in patients with concurrent infections. Using an enzyme-linked immunospot assay that reflects ongoing immune status in vivo, we enumerated spot-forming cells (SFCs) for interferon (IFN)-gamma, interleukin (IL)-4, and IL-12 in peripheral blood from 56 patients with hematological disorders. Eleven patients had viral, fungal, or bacterial systemic infections during first 10 weeks posttransplant. Of these, six patients with grade 0-I aGVHD showed normal levels of IFN-gamma SFCs. On the other hand, IFN-gamma SFCs were elevated in five patients with grade II-IV aGVHD. These data indicate that increased IFN-gamma SFCs seemed to be correlated with clinically significant aGVHD, but not with infection itself. IL-4 and IL-12 SFCs increased in some patients with infections, irrespective of the presence of aGVHD. Thus, IFN-gamma SFCs may be used to distinguish systemic infections from aGVHD.
ISSN:0041-1337
1534-6080
DOI:10.1097/01.tp.0000200303.00813.a8